SenzaGen
  • Home
  • Services
    • At a glance
      • Explore our services
      • Who we work with
      • GLP
    • GARD: Skin and Respiratory Sensitization Testing
      • GARDskin: OECD 442E
      • GARDpotency: OECD TGP 4.106
      • GARDskin Medical Device: ISO 10993-10
      • GARDskin Dose-Response
      • GARDair
      • “Difficult-to-test” samples
    • Regulatory Toxicity Testing
      • Skin corrosion: OECD 431
      • Skin irritation: OECD 439
      • Skin sensitization: OECD 442C, 442D, 442E
      • Skin absorption: OECD 428
      • Eye irritation: OECD 492, 492B
      • Phototoxicity: OECD 432, 498
      • Genotoxicity: OECD 471, 487
      • Full list of regulatory tests
    • Medical Device Services
      • Biological evaluation
      • Biocompatibility testing
        • Cytotoxicity: ISO 10993-5
        • Irritation: ISO 10993-23
        • Skin sensitization: ISO 10993-10
      • Substance-based Medical Devices
        • Qualification — Mode of Action
        • Classification — ADME
      • Advisory
    • Toxicology Advisory
      • Areas of expertise
      • The team
      • Medical Devices
      • Cosmetics
      • Chemicals
      • Pharmaceuticals
  • Science
    • GARD Technology
    • Science Behind
    • Scientific Publications
    • Posters
    • Webinars
  • Company
    • About Us
    • Sustainability
    • Career
    • Partners
  • Investors
    • SenzaGen at a Glance
    • Financial Reports
    • Press Releases
    • The Share
    • Analyst Coverage
    • Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Auditor
      • Nomination Committee
      • Annual General Meeting
    • Calendar
    • Prospekt / Emission
  • News and Events
    • Press Releases
    • News Posts
    • Event Calendar
  • Contact
  • Get a quote
  • Search
  • Menu Menu

Vatorpodden – intervju med VD och styrelseordförande

1 September, 2017

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://senzagen.com/wp-content/uploads/2017/07/e9262d9e897187a751b838082c4fe811.jpeg 400 266 Malin Bergholm https://senzagen.com/wp-content/uploads/2017/01/LoggaSquare_RGB_liten_HF.png Malin Bergholm2017-09-01 12:16:272018-08-23 15:41:00Vatorpodden – intervju med VD och styrelseordförande

Quick Links

Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions

Pages

  • Home
  • Services
  • Investors
  • Contact
  • News and Events

Follow Us

SUBSCRIBE TO PRESS RELEASES

SenzaGen’s chairman Carl Borrebaeck has received the Biotech Builders...SenzaGen offentliggör prospekt inför listning på Nasdaq First North
Scroll to top

Subscribe


Prenumerera